Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome

<h3>Objective: </h3><p dir="ltr">To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS).</p><p dir="ltr"><br></p><h3>Design: </h3><p dir="ltr&qu...

Full description

Saved in:
Bibliographic Details
Main Author: Noora Al-Hail (18140287) (author)
Other Authors: Alexandra E. Butler (6189536) (author), Soha R. Dargham (3613250) (author), Ahmed Abou Seif (18140290) (author), Stephen L. Atkin (6684368) (author)
Published: 2019
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513521759289344
author Noora Al-Hail (18140287)
author2 Alexandra E. Butler (6189536)
Soha R. Dargham (3613250)
Ahmed Abou Seif (18140290)
Stephen L. Atkin (6684368)
author2_role author
author
author
author
author_facet Noora Al-Hail (18140287)
Alexandra E. Butler (6189536)
Soha R. Dargham (3613250)
Ahmed Abou Seif (18140290)
Stephen L. Atkin (6684368)
author_role author
dc.creator.none.fl_str_mv Noora Al-Hail (18140287)
Alexandra E. Butler (6189536)
Soha R. Dargham (3613250)
Ahmed Abou Seif (18140290)
Stephen L. Atkin (6684368)
dc.date.none.fl_str_mv 2019-09-25T03:00:00Z
dc.identifier.none.fl_str_mv 10.3389/fendo.2019.00659
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Creatine_Kinase_Is_a_Marker_of_Metabolic_Syndrome_in_Qatari_Women_With_and_Without_Polycystic_Ovarian_Syndrome/25390666
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
polycystic ovarian syndrome
creatine kinase
inflammation
obesity
metabolic syndrome
dc.title.none.fl_str_mv Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Objective: </h3><p dir="ltr">To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS).</p><p dir="ltr"><br></p><h3>Design: </h3><p dir="ltr">Comparative cross-sectional analysis.</p><p dir="ltr"><br></p><h3>Methods: </h3><p dir="ltr">Demographic and metabolic data from Qatari women aged 18–40 years from the Qatar Biobank (97 diagnosed with PCOS, 563 controls). The primary outcome was the association between plasma CK and features of metabolic syndrome.</p><p dir="ltr"><br></p><h3>Results: </h3><p dir="ltr">CK increased when the waist circumference was >80 cm (p < 0.015) and when associated with 2 or more features of the metabolic syndrome (p < 0.01). CK correlated with BMI (p < 0.003) but not with waist/hip ratio. Overall, CK did not differ between PCOS and controls, rising equally in both as body mass index (BMI) increased. C reactive protein (CRP) was higher in obese PCOS (P < 0.05) compared to controls, but did not correlate with CK (p > 0.05).</p><p dir="ltr"><br></p><h3>Conclusion: </h3><p dir="ltr">CK was associated with an increase in BMI, waist circumference >80 cm and 2 or more features of the metabolic syndrome, in accord with the central role of type II skeletal muscle fibers in energy metabolism and obesity. CK was, however, independent of the PCOS phenotype.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Endocrinology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fendo.2019.00659" target="_blank">https://dx.doi.org/10.3389/fendo.2019.00659</a></p>
eu_rights_str_mv openAccess
id Manara2_524236bf3e3db89b07956be0d8e08cd4
identifier_str_mv 10.3389/fendo.2019.00659
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25390666
publishDate 2019
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian SyndromeNoora Al-Hail (18140287)Alexandra E. Butler (6189536)Soha R. Dargham (3613250)Ahmed Abou Seif (18140290)Stephen L. Atkin (6684368)Biomedical and clinical sciencesClinical sciencespolycystic ovarian syndromecreatine kinaseinflammationobesitymetabolic syndrome<h3>Objective: </h3><p dir="ltr">To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS).</p><p dir="ltr"><br></p><h3>Design: </h3><p dir="ltr">Comparative cross-sectional analysis.</p><p dir="ltr"><br></p><h3>Methods: </h3><p dir="ltr">Demographic and metabolic data from Qatari women aged 18–40 years from the Qatar Biobank (97 diagnosed with PCOS, 563 controls). The primary outcome was the association between plasma CK and features of metabolic syndrome.</p><p dir="ltr"><br></p><h3>Results: </h3><p dir="ltr">CK increased when the waist circumference was >80 cm (p < 0.015) and when associated with 2 or more features of the metabolic syndrome (p < 0.01). CK correlated with BMI (p < 0.003) but not with waist/hip ratio. Overall, CK did not differ between PCOS and controls, rising equally in both as body mass index (BMI) increased. C reactive protein (CRP) was higher in obese PCOS (P < 0.05) compared to controls, but did not correlate with CK (p > 0.05).</p><p dir="ltr"><br></p><h3>Conclusion: </h3><p dir="ltr">CK was associated with an increase in BMI, waist circumference >80 cm and 2 or more features of the metabolic syndrome, in accord with the central role of type II skeletal muscle fibers in energy metabolism and obesity. CK was, however, independent of the PCOS phenotype.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Endocrinology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fendo.2019.00659" target="_blank">https://dx.doi.org/10.3389/fendo.2019.00659</a></p>2019-09-25T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fendo.2019.00659https://figshare.com/articles/journal_contribution/Creatine_Kinase_Is_a_Marker_of_Metabolic_Syndrome_in_Qatari_Women_With_and_Without_Polycystic_Ovarian_Syndrome/25390666CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/253906662019-09-25T03:00:00Z
spellingShingle Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
Noora Al-Hail (18140287)
Biomedical and clinical sciences
Clinical sciences
polycystic ovarian syndrome
creatine kinase
inflammation
obesity
metabolic syndrome
status_str publishedVersion
title Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
title_full Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
title_fullStr Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
title_full_unstemmed Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
title_short Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
title_sort Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
topic Biomedical and clinical sciences
Clinical sciences
polycystic ovarian syndrome
creatine kinase
inflammation
obesity
metabolic syndrome